• A double-blind, randomized crossover clinical study was carried out in Brazil
  
• Compare two brands of botulinum toxin type A in treating bleopharospasm and hemifacial spasm
  
• No difference between BTXA™ and the other brand in terms of subjective global improvement, response onset, efficacy duration, and incidence and severity of adverse events

Join ICBA now for more clinical papers.